ask="9.11"
ask_size="1000"
average_daily_volume="129468"
bid="7.97"
bid_size="400"
book_value="3.76"
change="-0.18"
change_from_200_day_moving_average="0.06"
change_from_50_day_moving_average="0.35"
change_from_52_week_high="-4.47"
change_From_52_week_low="2.44"
change_in_percent="-2.19%"
close="8.03"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="0.21"
ebitda="-8.83M"
eps_estimate_current_year="-2.72"
eps_estimate_next_quarter="-0.43"
eps_estimate_next_year="-3.36"
ex_dividend_date="N/A"
float_shares="7622000"
high="8.26"
high_52_weeks="12.50"
last_trade_date="3/14/2017"
last_trade_price="8.03"
last_trade_size="1355"
last_trade_time="4:00pm"
low="7.73"
low_52_weeks="5.59"
market_capitalization="152.92M"
moving_average_200_day="7.97"
moving_average_50_day="7.68"
name="Recro Pharma
Inc."
notes="N/A"
one_year_target_price="20.00"
open="8.26"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+0.74%"
percent_change_from_50_day_moving_average="+4.60%"
percent_change_from_52_week_high="-35.76%"
percent_change_from_52_week_low="+43.65%"
previous_close="8.21"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.18"
price_per_sales="2.25"
revenue="69.34M"
shares_outstanding="19043000"
short_ratio="4.88"
stock_exchange="NCM"
symbol="REPH"
volume="157558"
weeks_range_52="5.59 - 12.50"
